Hester Biosciences has informed about submission of a transcript of Earnings Conference Call held by the Management of the Company with investors on 6th November 2019 at 2.00 pm, to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30 September 2019.
The above information is a part of company’s filings submitted to BSE.